Keywords: ovo Nordisk, Insulin manufacturing, Russia, Investment

Ground-breaking on new Novo Nordisk plant in Russia

Article | 17 April 2012

Print This

Danish insulin giant Novo Nordisk (NOV: N) broke ground yesterday on a new $100 million plant in Russia that will formulate ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in